Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00243204
Recruitment Status : Terminated (FDA Hold May 2007)
First Posted : October 21, 2005
Last Update Posted : June 8, 2007
Sponsor:
Information provided by:
Point Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Primary Completion Date : No date given
Study Completion Date : No date given